Clinical trial Recruiting at 1 site Phase 4 Interventional Ages Any age to 18

Vitamin D2 with Calcitriol in kids with cholestasis and vitamin D deficiency

Official title: Accelerated Correction of Vitamin D Deficiency in Cholestatic Children: a Comparative Trial of Vitamin D2 Monotherapy vs Combination Therapy With Calcitriol

Run by Chulalongkorn University · NCT07670611 · Data updated 2026-11-12

This study tests whether adding calcitriol to vitamin D2 helps children with cholestasis and vitamin D deficiency reach healthier vitamin D levels.

More Vitamin D Deficiency trials

Quick facts

PhasePhase 4
Study typeInterventional
AgesAny age to 18 Years
SexAll
Enrollment54 (estimated)
SponsorChulalongkorn University
Academic / other
Locations1 site (Bangkok)
StatusRecruiting
StartedApril 28, 2026
Main results expectedNovember 10, 2026
Study endsApril 20, 2027
Registry record updatedAugust 3, 2026
Trial IDNCT07670611 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children under 18 with cholestasis and chronic liver disease who have vitamin D deficiency (25-OHD < 20 ng/mL).

Probably not a fit

Children with normal vitamin D levels, those unable to attend follow-up visits, or those with conditions that preclude study participation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 4 interventional trial compares vitamin D2 alone to vitamin D2 plus calcitriol in children with cholestasis and chronic liver disease who are deficient in vitamin D. Participants are followed over several months to see which approach raises 25-hydroxyvitamin D levels more and whether adequate levels are reached at 3 and 6 months, while monitoring safety signals such as high calcium or phosphorus. The study will help determine if the combination is safer or more effective than vitamin D2 alone in this specific pediatric population.

Why it matters

Potential benefit: If successful, the combination could more effectively correct vitamin D deficiency in this group, potentially improving bone and overall health.

How similar studies have gone: Some prior approaches with vitamin D and calcitriol have shown potential benefits in liver disease contexts, but this exact combination in this pediatric cholestasis population is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients younger than 18 years of age.
* Patients diagnosed with cholestasis, defined as direct/conjugated bilirubin \>1 mg/dL for more than 1 month.
* Patients diagnosed with chronic liver disease.
* Patients with vitamin D deficiency, defined as serum 25-hydroxyvitamin D (25-OHD) level \<20 ng/mL, according to the Endocrine Society Clinical Practice Guideline.

Exclusion Criteria:

* Pre-existing hypercalciuria, screened by urine calcium testing before enrollment.
* Patients with benign or malignant tumors.
* Patients with renal tubular defects, screened by electrolyte testing before enrollment.
* Patients currently receiving anticonvulsant therapy.
* Patients who do not attend scheduled follow-up visits.

Where it's running

  • King Chulalongkorn Memorial Hospital
    Bangkok, Thailand
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.